Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bulk RNA-seq of: HUVECs co-incubated with CYR61-treated mouse bone marrow-derived macrophages CYR61-treated murine bone marrow-derived macrophages CYR61-treated HUVECs and CYR61-treated human THP1 monocytes

ABSTRACT: Bulk RNA-seq of: HUVECs co-incubated with CYR61-treated mouse bone marrow-derived macrophages CYR61-treated murine bone marrow-derived macrophages CYR61-treated HUVECs and CYR61-treated human THP1 monocytes

PROVIDER: PRJNA917714 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22963609_1.fastq.gz	Fastqsanger.gz
	SRR22963609_2.fastq.gz	Fastqsanger.gz
	SRR22963610_1.fastq.gz	Fastqsanger.gz
	SRR22963610_2.fastq.gz	Fastqsanger.gz
	SRR22963611_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 138

Similar Datasets

RNA-seq of CYR61-treated murine bone marrow-derived macrophages

Project description:We assess the effect of CYR61 treatment on the transcriptome of mouse bone marrow-derived macrophages.

2023-10-18 | GSE222100 | GEO

RNA-seq of CYR61-treated murine bone marrow-derived macrophages

Project description:RNA-seq of CYR61-treated murine bone marrow-derived macrophages

| PRJNA917718 | ENA

RNA-seq of human umbilical vein endothelial cells co-incubated with CYR61-treated mouse bone marrow-derived macrophages

Project description:We assess the transcriptional changes when human umbilical vein endothelial cells are co-incubated with naïve or CYR61-activated mouse bone marrow-derived macrophages.

2023-10-18 | GSE222099 | GEO

Bulk RNA-seq of: HUVECs co-incubated with CYR61-treated mouse bone marrow-derived macrophages; CYR61-treated murine bone marrow-derived macrophages; CYR61-treated HUVECs; and CYR61-treated human THP1 monocytes

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-10-18 | GSE222102 | GEO

RNA-seq of human umbilical vein endothelial cells co-incubated with CYR61-treated mouse bone marrow-derived macrophages

Project description:RNA-seq of human umbilical vein endothelial cells co-incubated with CYR61-treated mouse bone marrow-derived macrophages

| PRJNA917717 | ENA

RNA-seq of CYR61-treated THP1 human monocytes

Project description:RNA-seq of CYR61-treated THP1 human monocytes

| PRJNA975085 | ENA

Conditioned medium from bone marrow derived macrophages

Project description:Conditioned medium (CM) from bone marrow derived macrophages untreated or treated with LPS was collected and filtered through a 0.22-μm filter. The filtered CM was sequentially fractionated with 50-kDa and 100-kDa Amicon filters. The 50–100 kDa fraction of CM was analyzed by mass spectrometry.

2022-11-01 | PXD034550 | JPOST Repository

RNA-seq of CYR61-treated THP1 human monocytes

Project description:We assess the effects of CYR61 treatment on the transcriptome of human THP1 monocytes.

2023-10-18 | GSE233125 | GEO

CEBPB Immunoprecipitation from Bone Marrow Derived Macrophages

Project description:Data from the immunoprecipitation of CEBPB from bone marrow derived macrophages.

2020-03-17 | MSV000085112 | MassIVE

CYR61 orchestrates NASH fibrosis through SYK-NFκB-PDGF signaling in monocyte-derived macrophages [bulk RNA-seq]

Project description:Obesity is increasing worldwide and leads to a multitude of metabolic diseases including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatosis (NASH). Here we examine the role of CYR61 in liver fibrosis and inflammation and its potential as a therapeutic target. Loss of CYR61 during NASH injury improves glucose tolerance, decreases liver inflammation and reduces fibrosis. CYR61 activates signaling in monocytes and monocyte-derived macrophages promoting a pro-inflammatory/pro-fibrotic phenotype through a CYR61/SYK/NFKB signaling cascade. In vitro, CYR61 activates Pdgfa and Pdgfb expression in macrophages in a NFκB-dependent manner. Ultimately, we identify a potential therapeutic for NASH: a CYR61-blocking antibody that reduces fibrotic injury and CYR61-driven signaling in macrophages in vitro and in vivo. This study demonstrates that CYR61 is a key driver of liver inflammation and fibrosis and a strong therapeutic target for treatment of NAFLD/NASH.

2023-10-02 | GSE199637 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data